Clinical Trial Update: Testing if PDR-001 Can Safely and Effectively Remove Harmful Brain Protein in Parkinson's Disease [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update indicates that PDR-001 is being studied to remove a harmful brain protein in Parkinson's disease and is currently recruiting. No r…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• PDR-001

Snippet

Sponsor: Ruijin Hospital | Conditions: Parkinson Disease (PD) | Phase 1 | Status: RECRUITING